Skip to main content

2020 Roundup Risk Assessment To Be Dropped By EPA

2020 Roundup Risk Assessment To Be Dropped By EPA

2020 Roundup Risk Assessment To Be Dropped By EPA

Introduction

Federal environmental inspectors are dropping a contentious 2020 risk assessment on the link between Roundup and cancer, which featured the weedkiller's active key component, glyphosate.

The previous judgement by the United States Environmental Protection Agency (EPA) claimed that there was no proof that glyphosate caused cancer, which sparked an outcry in the scientific community and among consumer advocacy groups. As a result, the EPA was sued in March 2020, and the Ninth Circuit Court of Appeals ruled earlier this year that the agency had failed to follow its own criteria in producing the previous glyphosate assessment, ordering the agency to again review the risk by October 1.

The EPA informed the court last week that it will no longer pursue the lawsuit and is withdrawing the assessment because it cannot meet the court-imposed deadline, leaving glyphosate without a cancer risk assessment until it is reviewed again in 2026.

EPA officials emphasized that the agency's scientific conclusions have not changed, and that the removal of the assessment does not imply that regulators now think glyphosate causes cancer.

Glyphosate is the active component in Roundup and other weed killers that are extensively sold to consumers in the United States. The last EPA glyphosate safety evaluation was heavily criticized because it appeared to disregard warnings made by the World Health Organization's International Agency for Research on Cancer (IARC) in 2015, which opted to designate glyphosate as a likely carcinogen.

Following that warning, Bayer and its Monsanto subsidiary faced thousands of Roundup lawsuits filed by former Roundup users who developed non-lymphoma, Hodgkin's and internal documents were discovered that revealed the companies provided false and misleading information to consumers and regulators for years, implying glyphosate does not cause cancer.

Due to the complexities of the problems involved, the EPA now claims it will not be able to complete the evaluation until 2026. The agency has stated that it would not meet the October 1 court-ordered deadline, which left only 106 days to conduct the evaluation. Instead, the agency claims it will take four years to finish the review.

Depending on the severity of the findings, an EPA evaluation that finds glyphosate to be a cancer-causing chemical and a concern to the environment might result in additional limits or even Roundup recalls.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Walgreens Settles Federal Opioid Case for $300 Million

Categories: Opioids

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.

The U.S. Department of Justice announced on Monday…

Study: Opioid Use in Pregnancy May Shrink Newborn Brains

Categories: Opioids

New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…

Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting

Categories: Opioids

The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…

🛠️ You Have Unfinished Work. We’ll Finish It — Free Trial.            
Free Trial + 25% Off All DLs & Med Review Case Backlog!

Only 12 Firms Can Join – First Come, First Served